Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
International Pharmacopsychiatry|January 1, 1982
A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressivesW Guy, T A Ban, J P McEvoy, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1980
Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placeboJ P McEvoy, W F Sheridan, W R Stewart, et al.
The Journal of Nervous and Mental Disease|January 1, 1989
Insight in schizophrenia. Its relationship to acute psychopathologyJ P McEvoy, L J Apperson, P S Appelbaum, et al.
Faraday Discussions|February 24, 2001
Fast voltammetric studies of the kinetics and energetics of coupled electron-transfer reactions in proteinsF A Armstrong, R Camba, H A Heering, et al.
Psychosis|August 26, 2025
Childhood Trauma in People with Psychosis: Implications for Emotion Awareness and RegulationS A Miller, L H Ospina, B Ozomaro, et al.
Archives of General Psychiatry|January 1, 1995
Pharmacotherapy of impaired affect in recovering schizophrenic patientsG E Hogarty, J P McEvoy, R F Ulrich, et al.
Archives of General Psychiatry|September 1, 1988
Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled studyG E Hogarty, J P McEvoy, M Munetz, et al.
Molecular Psychiatry|March 3, 2010
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugsD E Adkins, K Aberg, J L McClay, et al.
Schizophrenia Research|August 5, 2006
Olanzapine and haloperidol in first episode psychosis: two-year dataA I Green, J A Lieberman, R M Hamer, et al.
Schizophrenia Research|May 26, 2012
Heritability of functioning in families with schizophrenia in relation to neurocognitionR M Savage, H W Wiener, V Nimgaonkar, et al.
Pageof 6